Gustave Roussy Institut
Gustave Roussy Institut
Villejuif, France, France1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Dose-Expansion Modular Study To Explore the Safety, Tolerability, and Anti-tumor Activity of HER3- DXd Monotherapy and Combinations in Patients With Inoperable Advanced Breast Cancer (ABC) After Progression on T-DXd | Advanced Breast Cancer; Breast Cancer Metastatic; HER2 Low Breast Carcinoma; HER2-positive Metastatic Breast Cancer | Recruiting | Phase 1 / Phase 2 | 2026-09-04 | NCT06298084 |